XML 17 R3.htm IDEA: XBRL DOCUMENT v3.24.3Close
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2024
Jun. 30, 2024
Current assets    
Cash and cash equivalents $ 278 $ 202
Receivables, net 595 695
Inventories, net 594 637
Prepaid expenses and other current assets 109 88
Total current assets 1,576 1,622
Property, plant and equipment, net of accumulated depreciation and amortization of $2,798 and $2,821, respectively 1,242 1,315
Operating lease right-of-use assets 341 360
Goodwill 1,233 1,228
Trademarks, net 503 538
Other intangible assets, net 78 143
Other assets 524 545
Total assets 5,497 5,751 Close
Current liabilities    
Notes and loans payable 4 4
Current operating lease liabilities 83 84
Accounts payable and accrued liabilities 1,472 1,486
Income taxes payable 20 0
Total current liabilities 1,579 1,574
Long-term debt 2,482 2,481
Long-term operating lease liabilities 315 334
Other liabilities 874 848
Deferred income taxes 23 22
Total liabilities 5,273 5,259 Close
Commitments and contingencies
Stockholders’ equity    
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding 0 0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of September 30, 2024 and June 30, 2024; and 123,673,684 and 124,201,807 shares outstanding as of September 30, 2024 and June 30, 2024, respectively 131 131
Additional paid-in capital 1,297 1,288
Retained earnings 31 250
Treasury stock, at cost: 7,067,777 and 6,539,654 shares as of September 30, 2024 and June 30, 2024, respectively (1,252) (1,186)
Accumulated other comprehensive net (loss) income (147) (155)
Total Clorox stockholders’ equity 60 328
Noncontrolling interests 164 164
Total stockholders’ equity 224 492 Close
Total liabilities and stockholders’ equity $ 5,497 $ 5,751